Coronaviridae (genetics) < Coronavirus (MeSH) < Coronavirus (drug effects)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Coronavirus (MeSH)

Number of relevant bibliographic references: 20.

Ident.	Authors (with country if any)	Title
000111 (2021)	L. Ratiani ; S. Gegechkory ; K. Machavariani ; T. Shotadze ; T. Sanikidze [Géorgie (pays)] ; N. Intskirveli	THE PECULIARITY OF COVID- 19 GENOME AND THE CORONAVIRUS RNA TRANSLATION PROCESS AS APOTENTIAL TARGET FOR ETIOTROPIC MEDICATIONSWITH ADENINE AND OTHER NUCLEOTIDE ANALOGUES (REVIEW).
000260 (2021)	Keisuke Kuroda [Japon] ; Cong Li [Japon] ; Kiran Dhangar [Inde] ; Manish Kumar [Inde]	Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters.
000724 (2021)	Ennio Giulio Favalli [Oman] ; Maria Gerosa [Italie] ; Antonella Murgo [Italie] ; Roberto Caporali [Italie]	Are patients with systemic lupus erythematosus at increased risk for COVID-19?
000802 (2020)	William H. Frishman [États-Unis]	The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
000866 (2020)	Paisan Ruamviboonsuk [Thaïlande] ; Timothy Y Y. Lai [République populaire de Chine] ; Andrew Chang [Australie] ; Chi-Chun Lai [Taïwan] ; William F. Mieler [États-Unis] ; Dennis S C. Lam [République populaire de Chine]	Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
000951 (2020)	Raúl Bozzo [Argentine] ; Fabiana Ibelli [Argentine] ; Dario Scublinsky [Argentine]	[Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic].
000A71 (2020)	Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie]	To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.
000D59 (2020)	Yuli Guzman-Prado [Royaume-Uni]	Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
001031 (2020)	Pasquale Pagliano [Italie] ; Ornella Piazza [Italie] ; Francesco De Caro [Italie] ; Tiziana Ascione [Italie] ; Amelia Filippelli [Italie]	Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to Healthcare Workers Exposed to Coronavirus Disease 2019?
001138 (2020)	Robert O. Bonow [États-Unis] ; Adrian F. Hernandez [États-Unis] ; Mintu Turakhia [États-Unis]	Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.
001264 (2020)	János Tomcsányi ; Krist F Tomcsányi	Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine
001377 (2020)	F. Diurno [Italie] ; F G Numis ; G. Porta ; F. Cirillo ; S. Maddaluno ; A. Ragozzino ; P. De Negri ; C. Di Gennaro ; A. Pagano ; E. Allegorico ; L. Bressy ; G. Bosso ; A. Ferrara ; C. Serra ; A. Montisci ; M. D'Amico ; S. Schiano Lo Morello ; G. Di Costanzo ; A G Tucci ; P. Marchetti ; U. Di Vincenzo ; I. Sorrentino ; A. Casciotta ; M. Fusco ; C. Buonerba ; M. Berretta ; M. Ceccarelli ; G. Nunnari ; Y. Diessa ; S. Cicala ; G. Facchini	Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.
001473 (2020)	Maurizio Guastalegname [Italie] ; Alfredo Vallone [Italie]	Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
001490 (2020)	Tian Xia [République populaire de Chine] ; Yanfeng Wang [République populaire de Chine]	Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.
001622 (2020)	Kamalan Jeevaratnam [Royaume-Uni]	Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
001623 (2020)	Srinadh Annangi [États-Unis]	Chloroquine and hydroxychloroquine for COVID-19: A word of caution.
001624 (2020)	Philippe Colson [France] ; Jean-Marc Rolain [France] ; Jean-Christophe Lagier [France] ; Philippe Brouqui [France] ; Didier Raoult [France]	Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.
001663 (2020)	Stephan D. Fihn [États-Unis] ; Eli Perencevich [États-Unis] ; Steven M. Bradley [États-Unis]	Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019.
001700 (2020)	Sanjith Saseedharan [Inde] ; Vaijanti Kadam [Inde] ; Roopa Karanam [Inde] ; Paritosh Baghel [Inde]	CT Scan Findings of Five Mildly Symptomatic COVID Patients from India.
001900 (2020)	Zakir Khan [Turquie, Pakistan] ; Yusuf Karata [Turquie] ; Hazir Rahman [Pakistan]	Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Coronavirus (MeSH)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Coronavirus (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Coronavirus (MeSH)
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021